218 related articles for article (PubMed ID: 25432436)
1. Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS).
Rupa-Matysek J; Lewandowski K; Lewandowska M; Wojtasińska E; Wojtaszewska ML; Walczak M; Bykowska K; Komarnicki M
Int J Hematol; 2015 Apr; 101(4):405-10. PubMed ID: 25432436
[TBL] [Abstract][Full Text] [Related]
2. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera.
Rottenstreich A; Kleinstern G; Krichevsky S; Varon D; Lavie D; Kalish Y
Eur J Intern Med; 2017 Jun; 41():49-54. PubMed ID: 27919526
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of different diagnostic tools for detection of acquired von Willebrand syndrome in patients with polycythemia vera or essential thrombocythemia.
Janjetovic S; Rolling CC; Budde U; Schneppenhem S; Schafhausen P; Peters MC; Bokemeyer C; Holstein K; Langer F
Thromb Res; 2022 Oct; 218():35-43. PubMed ID: 35988442
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients.
Mital A; Prejzner W; Bieniaszewska M; Hellmann A
Pol Arch Med Wewn; 2015; 125(12):914-20. PubMed ID: 26658493
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytapheresis for acquired von Willebrand syndrome in a patient with essential thrombocythemia and recent multivisceral transplantation.
Oyedeji O; Sheqwara J; Onwubiko I; Lopez-Plaza I; Nagai S; Otrock ZK
Transfusion; 2021 Nov; 61(11):3277-3280. PubMed ID: 34569071
[TBL] [Abstract][Full Text] [Related]
6. [Successful management of intraperitoneal bleeding with platelet apheresis and von Willebrand factor supplementation in a patient with essential thrombocythemia and acquired von Willebrand syndrome].
Ueki T; Takeshige K; Sumi M; Ueno M; Ichikawa N; Kobayashi H
Rinsho Ketsueki; 2017; 58(8):922-926. PubMed ID: 28883275
[TBL] [Abstract][Full Text] [Related]
7. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update.
Federici AB; Budde U; Castaman G; Rand JH; Tiede A
Semin Thromb Hemost; 2013 Mar; 39(2):191-201. PubMed ID: 23397553
[TBL] [Abstract][Full Text] [Related]
8. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
9. Fulminant Essential Thrombocythemia Associated with Acquired Von Willebrand Syndrome and Bleeding Episodes in a 14-year-old Girl.
Schneider C; Stutz-Grunder E; Lüer S; Keller P; Kremer Hovinga JA; Ammann RA; Karow A
Hamostaseologie; 2019 Nov; 39(4):404-408. PubMed ID: 30895567
[TBL] [Abstract][Full Text] [Related]
10. The course of acquired von Willebrand syndrome during pregnancy among patients with essential thrombocytosis.
Rottenstreich A; Kleinstern G; Amsalem H; Kalish Y
J Thromb Thrombolysis; 2018 Oct; 46(3):304-309. PubMed ID: 29654448
[TBL] [Abstract][Full Text] [Related]
11. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options.
Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ
Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation.
Giannini S; Solimando M; Fierro T; Baronciani L; Federici AB; Gresele P
Thromb Haemost; 2011 May; 105(5):921-4. PubMed ID: 21359411
[No Abstract] [Full Text] [Related]
13. Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia.
Kubo M; Sakai K; Hayakawa M; Kashiwagi H; Yagi H; Seki Y; Hasegawa A; Tanaka H; Amano I; Tomiyama Y; Matsumoto M
J Thromb Haemost; 2022 Jul; 20(7):1589-1598. PubMed ID: 35352474
[TBL] [Abstract][Full Text] [Related]
14. Triple-Negative Essential Thrombocythemia Complicated by Thrombosis and Acquired von Willebrand Disease in a Young Man.
Kanderi T; Puthenpura M; Shrimanker I; Sapna F; Felter SC
Am J Case Rep; 2020 Aug; 21():e924560. PubMed ID: 32829377
[TBL] [Abstract][Full Text] [Related]
15. Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count.
van Genderen PJ; Michiels JJ; van der Poel-van de Luytgaarde SC; van Vliet HH
Ann Hematol; 1994 Aug; 69(2):81-4. PubMed ID: 8080884
[TBL] [Abstract][Full Text] [Related]
16. Acquired von Willebrand syndrome (AvWS).
Drenko P; Přenosilová P; Lavičková A
Vnitr Lek; 2022; 68(E-4):16-19. PubMed ID: 36220373
[TBL] [Abstract][Full Text] [Related]
17. An unusual cause of cerebellar hemorrhage in a young patient: essential thrombocythemia.
Adam R; Priglinger M; Harrington T; Gottlieb D; Krause M
J Stroke Cerebrovasc Dis; 2014; 23(5):e373-4. PubMed ID: 24582788
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnostic and treatment difficulties in a patient with acquired von Willebrand syndrome.
Magyari F; Kracskó B; Bedekovics J; Bereczky Z; Illés Á; Schlammadinger Á
Hematology; 2021 Dec; 26(1):301-304. PubMed ID: 33663351
[TBL] [Abstract][Full Text] [Related]
19. Acquired von Willebrand Syndrome in Children.
Sandrock-Lang K; Glonnegger H; Zieger B
Hamostaseologie; 2022 Apr; 42(2):117-122. PubMed ID: 35488164
[TBL] [Abstract][Full Text] [Related]
20. Acquired von Willebrand syndrome: focused for hematologists.
Franchini M; Mannucci PM
Haematologica; 2020 Aug; 105(8):2032-2037. PubMed ID: 32554559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
